Robert Lindsay - Böcker

Diabetes is one of the most common medical conditions to complicate pregnancy. Gestational diabetes (diabetes with onset or first recognition in pregnancy) may complicate between 2 and 20% of pregnancies depending on the criteria used. Type 1 or Type 2 diabetes complicates over 1 in 300 pregnancies, and both have major implications for mother and child. The management of diabetes during pregnancy has seen a number of major innovations in recent years. Insulin analogues have been introduced, and technical innovations include improvements in insulin pumps and the development of continuous glucose monitoring devices. The evidence base for the management of gestational diabetes has improved markedly, and the investigations based around the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study promise to revolutionise our understanding of the risks of adverse outcomes in pregnancy. The Australian Carbohydrate Intolerance Study (ACHOIS) has demonstrated that identification and glycaemic management of gestational diabetes leads to reduction in birth weight, macrosomia and adverse pregnancy outcomes. Finally, recent randomised control trials have explored use of oral hypoglycaemics (metformin, glibenclamide) in pregnancy. Part of the Oxford Diabetes Library series, 'Diabetes in Pregnancy' summarizes the key aspects of the medical management of diabetes during pregnancy with an emphasis on clinical management. The volume is designed for all members of the multidisciplinary team and will act as a practical introduction particularly for obstetricians and endocrinologists in training.

It seems particularly appropriate that this pioneering collection of papers should be dedicated to Donald Sholl since those of us who count, measure, and reconstruct elements of the neural en~emble are all very much in his debt. Sholl was certainly not the first to attempt quantification of certain aspects of brain structure. No computers were available to him for the kind of answers he sought, and some of his answers - or rather his interpretations - may not stand the test of time. But we remember him because of the questions he asked and for the reasons he asked them. At a time when the entire family of Golgi techniques was in almost total eclipse, he had the judgment to rely on them. And in a period when the canonical neuron was a perfect sphere (the enormous dendritic superstructure being almost forgotten), he was one of a very few who looked to dendrite extension and pattern as a prime clue to the overall problem of neuronal connectivity.

The second edition of Osteoporosis in Clinical Practice provides a concise review of the current knowledge of osteoporosis. It is aimed at the busy practitioner who is increasingly involved in the management of osteoporosis and who wants accurate and practical answers to questions that arise in daily clinical practice. All the major aspects are covered including diagnosis, fractures, prevention and treatment. Concise chapters have been written by recognised experts in the area providing the reader with the most up-to-date and authoritative knowledge on each of the topics discussed. This makes the book an invaluable source of reference for those in primary care who are increasingly having to deal with patients with osteoporosis in their daily clinical practice. A must-have for every clinician treating patients with osteoporosis. It gives the latest information on diagnosis and treatment, founded on evidence-based medicine.